A. Rodriguez-Izquierdo

Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

C. Martínez, Arturo Pereira, R. García-Sanz, 2022, Annals of Hematology.

Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin lymphoma: Real-life experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO).

C. Martínez, J. Bargay, R. García-Sanz, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.